Zayn Venture Capital

Zayn Venture Capital is one of Pakistan’s leading venture firms, deploying $1M-$5M cheques at Seed and Series A across high-growth technology verticals including digital health and AI/ML in healthcare. The firm’s capital base draws meaningfully from regional family offices and diaspora HNIs, which gives Zayn flexibility on cheque size within its declared range and the ability to lead or co-lead rounds. For founders, Zayn is best understood as a pragmatic generalist with selective health-tech and AI conviction, useful as a domestic anchor in syndicates that include Indus Valley Capital, Sturgeon, or international funds. The right founder profile is a Pakistani or South Asian operator building digital health, telemedicine, or AI-enabled clinical platforms with early traction and a credible regional expansion story. Founders running deep biotech, hospital networks, or pre-product experiments are a poor fit. Entry path is via a portfolio CEO, the Karachi and Lahore founder community, or warm introductions from co-investing funds. In the pitch, lead with revenue traction, clinical or provider partnerships, capital efficiency, and a Series A plan that names likely cross-border leads. Caveats: Pakistan’s macro and currency volatility constrain valuation expectations and follow-on round sizing, so founders should be realistic about international Series A pricing and time their rounds with FX hedging in mind. Zayn is not branded as an AI specialist, so AI-heavy founders should expect to defend model claims with external technical advisors. Public deal disclosures are uneven, so request a recent portfolio sheet to confirm pacing, vintage, and reserves policy. Founders should also clarify the fund’s appetite for healthcare specifically versus broader tech, since the venture book is generalist by design.